The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases

The prevalence of acute respiratory diseases, the particular severity of their course, as well as the frequent relapses and complications require constant search for new, more effective and safe medicines for their prevention and treatment and introduction of these drugs into clinical practice. Gene...

Full description

Bibliographic Details
Main Authors: M. Q. Gulzoda, A. U. Rahmonov, K. S. Makhsudov, R. S. Musoev, S. M. Musozoda, O. S. Shpychak
Format: Article
Language:Ukrainian
Published: The State Expert Center of the Ministry of Health of Ukraine 2020-10-01
Series:Фармацевтичний журнал
Subjects:
Online Access:https://pharmj.org.ua/index.php/journal/article/view/1063/991
id doaj-ca0c9d54fa064655884521859d1c7409
record_format Article
spelling doaj-ca0c9d54fa064655884521859d1c74092020-11-25T04:07:22ZukrThe State Expert Center of the Ministry of Health of UkraineФармацевтичний журнал0367-30572617-96282020-10-015516010.32352/0367-3057.5.20.06The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseasesM. Q. Gulzoda0https://orcid.org/0000-0002-1641-1555A. U. Rahmonov1https://orcid.org/0000-0002-0535-0291K. S. Makhsudov2https://orcid.org/0000-0002-0857-6181R. S. Musoev3https://orcid.org/0000-0001-5710-0027S. M. Musozoda4https://orcid.org/0000-0001-8512-8019O. S. Shpychak5https://orcid.org/0000-0002-3015-8584Avicenna Tajik State Medical University, Dushanbe, TajikistanTajik National University, Dushanbe, TajikistanTajik National University, Dushanbe, TajikistanTajik National University, Dushanbe, TajikistanTajik National University, Dushanbe, TajikistanInstitute for Advanced Studies of Pharmacy Specialists, National University of Pharmacy, Kharkіv, UkraineThe prevalence of acute respiratory diseases, the particular severity of their course, as well as the frequent relapses and complications require constant search for new, more effective and safe medicines for their prevention and treatment and introduction of these drugs into clinical practice. Generally, most of the medications used in the treatment of acute respiratory viral infections have a number of side effects. Currently, one of the promising areas of pharmacy is the study of biologically active substances, the medicinal plant raw material, and production of extracts and herbal medicines based on them. Objective – pharmaceutical development of a scientifically based composition, technology for obtaining anti-inflammatory and antimicrobial tablets developed on the basis of a selected and standardized plant substance-a thick extract of the leaves of sage nutmeg, which grows in Tajikistan. When solving the task used the methods of evaluating the technological properties of LRS, physico-chemical properties of plant extracts, physical and technological properties of the mass for tabletting, pharmaco-technological tests of the developed tabletsa study of quantitative content of biologically active substances was determined by Pharmacopoeia methods. The developed solid dosage form with thick extract of sage leaves can be registered as a medicinal product, and the developed technology of tablets with thick extract of sage leaves can be of interest to manufacturers of medicinal products from plant raw materials. The developed methods can be used in laboratories for the detection and quantitative determination of BAS in plant raw materials of Clary sage leaves and medicinal products from this LRS. Thus, based on the results of pharmacological and technological research, we have developed a technology for obtaining a thick extract of sage nutmeg and tablets based on it for the treatment of otolaryngological diseases, which in turn is of interest for further research of the developed drug and its introduction into production.https://pharmj.org.ua/index.php/journal/article/view/1063/991tabletssolid dosage formpharmaco-technological characteristicsotolaryngological diseases
collection DOAJ
language Ukrainian
format Article
sources DOAJ
author M. Q. Gulzoda
A. U. Rahmonov
K. S. Makhsudov
R. S. Musoev
S. M. Musozoda
O. S. Shpychak
spellingShingle M. Q. Gulzoda
A. U. Rahmonov
K. S. Makhsudov
R. S. Musoev
S. M. Musozoda
O. S. Shpychak
The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases
Фармацевтичний журнал
tablets
solid dosage form
pharmaco-technological characteristics
otolaryngological diseases
author_facet M. Q. Gulzoda
A. U. Rahmonov
K. S. Makhsudov
R. S. Musoev
S. M. Musozoda
O. S. Shpychak
author_sort M. Q. Gulzoda
title The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases
title_short The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases
title_full The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases
title_fullStr The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases
title_full_unstemmed The pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases
title_sort pharmaco-technological studies of the tablet solid dosage form for the treatment of otolarynological diseases
publisher The State Expert Center of the Ministry of Health of Ukraine
series Фармацевтичний журнал
issn 0367-3057
2617-9628
publishDate 2020-10-01
description The prevalence of acute respiratory diseases, the particular severity of their course, as well as the frequent relapses and complications require constant search for new, more effective and safe medicines for their prevention and treatment and introduction of these drugs into clinical practice. Generally, most of the medications used in the treatment of acute respiratory viral infections have a number of side effects. Currently, one of the promising areas of pharmacy is the study of biologically active substances, the medicinal plant raw material, and production of extracts and herbal medicines based on them. Objective – pharmaceutical development of a scientifically based composition, technology for obtaining anti-inflammatory and antimicrobial tablets developed on the basis of a selected and standardized plant substance-a thick extract of the leaves of sage nutmeg, which grows in Tajikistan. When solving the task used the methods of evaluating the technological properties of LRS, physico-chemical properties of plant extracts, physical and technological properties of the mass for tabletting, pharmaco-technological tests of the developed tabletsa study of quantitative content of biologically active substances was determined by Pharmacopoeia methods. The developed solid dosage form with thick extract of sage leaves can be registered as a medicinal product, and the developed technology of tablets with thick extract of sage leaves can be of interest to manufacturers of medicinal products from plant raw materials. The developed methods can be used in laboratories for the detection and quantitative determination of BAS in plant raw materials of Clary sage leaves and medicinal products from this LRS. Thus, based on the results of pharmacological and technological research, we have developed a technology for obtaining a thick extract of sage nutmeg and tablets based on it for the treatment of otolaryngological diseases, which in turn is of interest for further research of the developed drug and its introduction into production.
topic tablets
solid dosage form
pharmaco-technological characteristics
otolaryngological diseases
url https://pharmj.org.ua/index.php/journal/article/view/1063/991
work_keys_str_mv AT mqgulzoda thepharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT aurahmonov thepharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT ksmakhsudov thepharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT rsmusoev thepharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT smmusozoda thepharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT osshpychak thepharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT mqgulzoda pharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT aurahmonov pharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT ksmakhsudov pharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT rsmusoev pharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT smmusozoda pharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
AT osshpychak pharmacotechnologicalstudiesofthetabletsoliddosageformforthetreatmentofotolarynologicaldiseases
_version_ 1724429094384304128